Skip to content

Clinical trials

Phase 3 Glioblastoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Phase: Phase 3 Country / region: China Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20122
20153
20161
20203
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status6
Active, not recruiting2
Completed2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sun Yat-sen University3
AbbVie1
Ascletis Pharmaceuticals Co., Ltd.1
Denovo Biopharma LLC1
Nuvation Bio Inc.1
Shandong Lanjin Pharmaceuticals Co.,Ltd1
Shanghai Proton and Heavy Ion Center1
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1
Universitätsmedizin Mannheim1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma11
Astrocytoma4
Glioma3
Oligodendroglioma2
Brain Neoplasms1
Gliosarcoma1
Lymphoma, Follicular1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.